U.S. Professional Services Stock News

Wondering if Celcuity at around $101 a share is still a smart buy after its huge run, or if you are late to the party? This breakdown will help you decide whether the current price matches the underlying value. The stock has climbed 1.8% over the last week, 32.8% in the last month, and an eye catching 675.6% year to date. Its 1 year gain of 692.5% and 3 year return of 881.0% show just how dramatically market expectations have shifted. Recent news flow around Celcuity has centered on growing...

MetLife (MET) has quietly outperformed the broader insurance group in recent sessions, with shares drifting higher as investors weigh its steady earnings growth, capital return profile, and how fairly the stock is currently priced. See our latest analysis for MetLife. That steady climb to around $79.82 comes after a patchy year for the share price, with short term share price returns recently turning positive even as the one year total shareholder return still hovers slightly negative. This...

If you are wondering whether Shopify is still worth buying after its huge run, or if the easy money has already been made, you are not the only one trying to figure out whether the current price makes sense. Over the last week the stock is up 3.8%. It has climbed 6.0% in the last month, 56.6% year to date, and 46.1% over the past year, while sitting around a recent close of $168.42. These gains have been supported by ongoing headlines around Shopify expanding its ecosystem, from partnerships...

If you are wondering whether Wayfair’s sharp comeback makes it a bargain or a trap at today’s price, you are not alone. This article is designed to help you cut through the noise. The stock has pulled back about 2% over the last week and roughly 17.1% over the last month, but it is still up an eye catching 102.6% year to date and about 69.9% over the past year. This highlights both strong momentum and elevated risk. Recent headlines have focused on Wayfair’s push to streamline operations and...

Arcutis Biotherapeutics (ARQT) has quietly put up an impressive run this year, with the stock more than doubling as investors warm to its dermatology pipeline, revenue growth, and improving path toward profitability. See our latest analysis for Arcutis Biotherapeutics. That move has not been a straight line, but the recent 30 day share price return of 25.35 percent and 90 day share price return of 68.29 percent, alongside a 1 year total shareholder return of 133.12 percent, shows momentum is...

Earlier this week, Upwork announced two new partnerships: one with embedded finance provider YouLend to offer on-platform financing to U.S. freelancers, agencies and small businesses, and another with OpenAI to help businesses more easily find talent with specific AI skills. Together, these agreements expand Upwork’s role from a pure talent marketplace into a broader work infrastructure platform, tying access to capital and AI-focused hiring more tightly into its ecosystem. We’ll now examine...

Champion Homes (SKY) just turned in another quietly impressive quarter, and the market is starting to notice. Strong sales, higher earnings, and hefty buybacks, plus fresh institutional interest, are giving the stock new momentum. See our latest analysis for Champion Homes. The recent executive transition at the finance helm and fresh institutional buying are landing just as momentum improves, with a 90 day share price return of 17.22% and a five year total shareholder return of 179.92%,...

Recently, commentary around ePlus (NASDAQ:PLUS) highlighted that its sales have been flat for the past two years and are projected to fall over the next 12 months as demand for its IT solutions fades. This shift in demand expectations raises questions about the durability of ePlus’s business model and its ability to sustain prior operating trends. We’ll now explore how weakening demand and expectations for declining sales could reshape ePlus’s existing investment narrative. These 10...

Recent commentary on Labcorp Holdings has highlighted persistently slow organic sales growth, declining adjusted operating margins, and a weaker return on invested capital, raising fresh concerns about its core laboratory and drug development operations. These trends suggest Labcorp may need to rethink its cost base and capital allocation, as investors question whether the company is still finding enough high-quality, profitable growth opportunities. Next, we’ll examine how concerns over...

Cushman & Wakefield (CWK) just moved to voluntarily deregister its ordinary shares with the SEC and pulled a related shelf registration, a regulatory pivot that immediately puts stock liquidity and future capital raising under the microscope. See our latest analysis for Cushman & Wakefield. The deregistration move comes after a busy stretch of Investor Day strategy updates, M&A comments and major client wins. It also lands while the share price sits at $15.24 with a solid year to date share...

Wondering if PROS Holdings at around $23 is a quietly mispriced opportunity or a value trap in disguise? You are not alone. This stock often flies under the radar despite operating in a high-potential niche of AI powered pricing and revenue optimization software. Over the last month the share price has inched up about 0.5%, contributing to an 8.2% gain year to date. However, that is still set against a rough 5 year journey that has left the stock down more than 50% from its earlier...

Market context and recent trading action YD Bio (YDES) has quietly turned heads after a sharp move over the past month, with the stock up roughly 43% even as its past 3 months performance remains deeply negative. See our latest analysis for YD Bio. That recent 1 month share price return of about 43% has only partially repaired earlier damage, leaving the 3 month share price return sharply negative even as the year to date share price return turns modestly positive. This suggests momentum is...

Photronics (PLAB) just turned in a mixed set of FY 2025 third quarter numbers, with revenue of about $210.4 million and EPS of $0.40, while trailing 12 month revenue sits around $856.2 million and EPS at $1.79 as margins have come under pressure from the prior year. The company has seen quarterly revenue hover in a tight band between roughly $211 million and $223 million over the last six reported periods, with EPS ranging from $0.15 to $0.69, which sets the stage for investors to focus...

Wondering if Range Resources is still a smart buy after its massive multi year run, or if most of the upside is already priced in? In this article, we break down what the market is really paying for. The stock has cooled off recently, down 6.0% over the last week and 4.1% over the past month, but it is still up 3.4% year to date, 4.4% over 1 year, 42.9% over 3 years, and an eye catching 450.2% over 5 years. Those moves sit against a backdrop of ongoing shifts in US natural gas demand,...

eToro Group (ETOR) has quietly slipped about 4% over the past week, even after an 8% gain over the past month, leaving the stock trading well below where it started the year. See our latest analysis for eToro Group. That pullback comes after a choppy year in which the year to date share price return is down sharply, even with a solid 1 month share price return suggesting sentiment may be stabilising rather than accelerating. If eToro’s swings have you reassessing your watchlist, it could be a...

Braze (BRZE) just posted its Q3 2026 numbers with investors zeroing in on how its recent top line near $180 million and ongoing negative EPS compare with the company’s still sizeably negative net income profile. The company has seen quarterly revenue move from about $135 million in Q1 2025 to roughly $180 million by Q2 2026, while basic EPS has stayed in the red, ranging between about -$0.17 and -$0.35 over that stretch. This underscores how growth is still bumping up against stubborn losses...

Daqo New Energy recently expanded its polysilicon production capacity and integrated systems to enhance output quality and cost efficiency, supporting global photovoltaic supply chains. This push to scale high-purity polysilicon production underscores Daqo’s effort to align its operations with rising global solar manufacturing demand. Next, we’ll examine how Daqo’s expanded polysilicon capacity and efficiency focus may influence the company’s existing investment narrative. The best AI stocks...

Genasys (GNSS) just posted its FY 2025 third quarter numbers, with revenue of about $9.9 million and a basic EPS loss of roughly $0.14, setting the stage for another closely watched update on its path toward profitability. The company has seen quarterly revenue move from about $5.7 million in Q2 FY 2024 to $6.7 million in Q4 FY 2024 and then to the current $9.9 million print in Q3 FY 2025. Over the same stretch, basic EPS has ranged from a $0.26 loss to the latest $0.14 loss, keeping margins...

In early December 2025, ICON plc released findings from two extensive biotech sector surveys and a separate clinical trial site survey, revealing resilient global R&D activity, rising funding pressures, shifting therapeutic focus areas, and growing reliance on AI and digital technologies to streamline drug development. The research highlights China’s increasing role in biotech innovation, alongside evidence that operational bottlenecks at trial sites and talent shortages in APAC are becoming...

ProAssurance (PRA) has quietly delivered a strong run for patient investors, with shares up roughly 53% year to date and about 44% over the past year, despite modest revenue contraction. See our latest analysis for ProAssurance. The latest leg of the rally has been more of a steady grind than a spike. The 90 day share price return of 1.26% has consolidated earlier gains as investors reprice ProAssurance for improving profitability, while its five year total shareholder return of 34.97% points...

Earlier this month, Resideo Technologies introduced the Honeywell Home X8S smart thermostat, featuring a large touchscreen, live video streaming from compatible doorbells, and an energy-efficiency focus for homeowners in the U.S. and Canada. The launch underscores how Resideo is leaning on Honeywell Home’s brand trust, survey-backed energy savings data, and pro-installer ecosystem to differentiate its newest smart thermostat offering. Next, we’ll examine how this feature-rich X8S launch,...

Energy Services of America (ESOA) just posted its FY 2025 third quarter numbers, with revenue of about $103.6 million and EPS of roughly $0.13, while trailing twelve month revenue sits near $385.6 million and EPS at about $0.17. The company has seen revenue move from roughly $85.9 million and EPS of about $1.06 in the third quarter of FY 2024 to $103.6 million and $0.13 respectively in the latest quarter, setting up a picture where the headline growth story now runs alongside much thinner...

Ross Stores (ROST) has just posted Q3 2026 results with revenue of about $5.6 billion, basic EPS of $1.59 and net income of roughly $512 million, setting the stage for another closely watched update from the off price chain. The company has seen quarterly revenue move from around $5.1 billion in Q3 2025 to $5.6 billion in Q3 2026, while basic EPS stepped up from $1.49 to $1.59 over the same period, giving investors a clearer view of how sales scale is feeding into per share profitability...

Uranium Energy (UEC) opened Q1 2026 with trailing twelve month revenue of about $66.8 million and a basic EPS of roughly -$0.21, underscoring that the company is still firmly in loss-making territory. Over the past few reported quarters, revenue has swung from $0 to $49.8 million while quarterly EPS has ranged from about -$0.02 to -$0.07, painting a picture of a business that can generate sales but has yet to convert that into consistent profitability or stable margins. See our full analysis...